Monday 23 Jun, 2025 04:48 PM
Site map | Locate Us | Login
   ITCONS E-Solutions bags Rs 47 lakh work order from PVVNL for manpower services    Northern Arc Capital rallies after Madhusudan Kela's fund picks stake    P&G Hygiene appoints Gaurav Bhartia as CFO    L T Foods Ltd leads losers in 'A' group    Zee Entertainment jumps on strategic business update    Munjal Showa Ltd leads losers in 'B' group    Solar Inds arm bags supply contract worth Rs 158-cr from Ministry of Defence    Volumes spurt at Chennai Petroleum Corporation Ltd counter    United Spirits Ltd down for fifth straight session    NBCC (India) gains after securing Rs 297-cr redevelopment order from MDA    Aditya Birla Lifestyle Brands lists on stock exchanges    Supreme Power hits the roof after bagging order worth Rs 16 cr    Ideaforge Tech hits the roof on bagging Rs 137-cr defence order for Mini UAVs    Bliss GVS Pharma Ltd leads gainers in 'B' group    Ideaforge Technology Ltd leads gainers in 'A' group 
Saravan Stocks
       
Hot Pursuit
Scrips, which has significant changes during the market hours.
Granules India receives one observation from USFDA following inspection at Telangana facility
23-Jun-25   09:36 Hrs IST

In a regulatory filing, the company stated that the USFDA conducted the inspection from 16 June to 20 June 2025. At the conclusion of the inspection, the USFDA issued a Form 483 with one observation.

The company stated that it will respond to this observation within the stipulated time frame.

The Bonthapally facility is one of the world's largest single-site paracetamol API manufacturing plants by volume. Along with paracetamol APIs, the company has also established metformin and guaifenesin API manufacturing units at the same site.

The official announcement was made on 20 June 2025, after market hours.

Granules India is primarily involved in the manufacturing and sale of active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates (PFIs), and finished dosages (FDs).

The company's consolidated net profit rose by 17.3% to Rs 152.03 crore, on a 2.4% increase in total revenue from operations to Rs 1,196.82 crore in Q4 FY25, compared to Q4 FY24.

The counter rose 0.31% to Rs 488.35 on the BSE.

Powered by Capital Market - Live News

   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com,  Mobile No: 7305522205
Hit Count : 42153501
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 56990 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. SSPL Securities Private Limited